Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-24 @ 5:12 PM
NCT ID:
NCT02717650
Eligibility Criteria:
INCLUSION
* Confirmed Diagnosis of CF (by genotype or positive sweat test)
* Aged 18yrs and older
* FEV1 ≥20% (Forced expiration in 1 sec)
* Stable baseline state. (Stable baseline state is defined as: clinically stable respiratory status, for at least 30 days, characterized by the absence of hospitalization and no changes in maintenance therapy during this period (Yankaskas et al 2004)).
EXCLUSION
* Febrile
* Haemoptysis
* Uncontrolled asthma
* Pneumothorax
* Cardiac issues
* Unreliable readings on pulse oximetry
* Pulmonary hypertension
* Unstable CF related diabetes (CFRD)
* Vascular issues
* Renal disease
* Pregnancy
* Body mass index (BMI) \<18.0
* Significant musculoskeletal issues
* Unable to safely follow instructions
(ATS/ACCP 2003; Hebestreit 2015)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02717650
Study Brief:
Protocol Section:
NCT02717650